Fny Investment Advisers, LLC Bristol Myers Squibb CO Call Options Transaction History

Fny Investment Advisers, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $173 - $194	3 New	3 $0
Q1 2021 Apr 12, 2021	SELL	$59.34 - $66.74 $22,549 - $25,361	-380 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $21,941 - $24,863	380 New	380 $23,000
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $164 - $192	-3 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $147 - $192	3 New	3 $0
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $2,007 - $2,220	-45 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $1,759 - $2,098	39 Added 650.0%	45 $2,000
Q3 2018 Oct 29, 2018	BUY	$55.19 - $62.25 $275 - $311	5 Added 500.0%	6 $0
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $50 - $62	1 New	1 $0

2,400

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $105B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.